Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis

BACKGROUND & OBJECTIVES: Hydroxychloroquine (HCQ), reported to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in in vitro studies, has been recommended for prophylaxis of COVID-19 in healthcare workers (HCWs). The objective of this study was to assess short-term...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Med Res
Main Authors: Faruqui, Atiya R., Xavier, Denis, Kamat, Sandhya K., Chandy, Sujith J., Medhi, Bikash, Tripathi, Raakhi K., Shetty, Yashashri C., Raj, John Michael, Kaushal, Sandeep, Balakrishnan, S., Atal, Shubham, Tripathi, Santanu K., Badyal, Dinesh K., Dikshit, Harihar, Roy, Sukalyan Saha, Trivedi, Niyati, Chatterjee, Suparna, Desai, Chetna, Tripathi, C.D., Rege, Nirmala N., Gupta, Pooja, Raveendran, R., Kaul, Rajni, Kshirsagar, Nilima A.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer - Medknow 2021
Assuntos:
Programme
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8184065/
https://ncbi.nlm.nih.gov/pubmed/33818480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_2294_20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados